SnagRx vs bmiMD: Compounded GLP-1 pricing and service comparison
SnagRx vs bmiMD is a direct comparison of two compounding-focused telehealth options for GLP-1 or GLP-1/GIP therapy. Early verdict: SnagRx is the lowest-cost annual plan for compounded semaglutide and emphasizes a price lock at every dose, while bmiMD centers on compounded tirzepatide with multi-month pricing tiers and 24/7 clinician access.
See SnagRx semaglutide pricing
How pricing and plans differ between SnagRx and bmiMD
Pricing is the clearest difference. SnagRx lists compounded semaglutide from $69/month on a 12-month plan and compounded tirzepatide from $119/month on a 12-month plan; month-to-month pricing is higher at $99 and $149 respectively. bmiMD presents tirzepatide with four billing options: $179 month-to-month, $159 for three months, $149 for six months, and $139 for a 12-month plan. Both vendors require a longer commitment to access the lowest monthly equivalent and state that compounded medications are not FDA-approved.
Five side-by-side criteria
| Criteria | SnagRx | bmiMD |
|---|---|---|
| Starting price | Semaglutide from $69/month (12-month plan); tirzepatide from $119/month (12-month plan) | Tirzepatide from $139/month (12-month plan); $179 month-to-month |
| Pricing model | 12-month plan lowers monthly rate; price locked flat at every dose and at renewal | Four billing options with lower long-term monthly equivalents; same price at every dose |
| Medication type | Compounded semaglutide and compounded tirzepatide only; not branded products | Compounded tirzepatide (GLP-1/GIP) only; not FDA-approved finished products |
| Clinician and access | Telemed prescribing by OpenLoop Health network; clinician review typically within 5 hours; clinician network covers 48 states | Clinician-reviewed online program with 24/7 clinician access; treatment available when a licensed clinician determines it is appropriate |
| Shipping and fulfillment | Next-day UPS/FedEx temperature-controlled shipping; named US 503A partner pharmacies; free shipping claimed | Free subscription shipping; medication prepared in state-licensed pharmacy and verified in labs |
| Refunds and guarantees | Full refund if prescription is declined; 6-month weight-loss guarantee referenced with terms | 100% refundable if not eligible for program; 100% risk free claim |
Clinician review, shipping speed, and pharmacy sourcing
Both providers emphasize clinician review and pharmacy fulfillment but with different specifics. SnagRx names OpenLoop Health as the clinician network and lists four named US 503A partner pharmacies, stating an OpenLoop clinician typically reviews intake within five hours and approved orders ship next-day via UPS or FedEx in temperature-controlled packaging. bmiMD notes state-licensed pharmacy preparation, independent lab verification, and online refills with deliveries timed to need, plus free subscription shipping and confirmation processes for strength.
Product type and regulatory notes
Neither provider offers FDA-approved branded finished products. SnagRx and bmiMD both provide compounded medications and include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. SnagRx explicitly states its compounded medications are produced in FDA-regulated facilities but that compounded products are not FDA-approved. bmiMD similarly states compounded medications are not FDA-approved.
Service differences: price lock, clinician access, and guarantees
SnagRx highlights a price lock at every dose and renewal, positioning that as protection from re-pricing during titration. bmiMD highlights flexible billing with a lowest monthly equivalent on the 12-month plan and 24/7 clinician access. SnagRx advertises a clinician review timeline and next-day shipping while also naming its clinics and pharmacies and citing LegitScript certification. bmiMD emphasizes online refills, verification in labs, and a 100 percent refundable policy if a patient is not eligible.
Check SnagRx price lock and details
Quick practical implications for patients
If your priority is the lowest annual-plan monthly price for compounded semaglutide, SnagRx lists semaglutide from $69/month on a 12-month plan and promises a flat price at every dose. If you want compounded tirzepatide and flexible multi-month options with 24/7 clinician access, bmiMD lists tirzepatide from $139/month on a 12-month plan with shorter-term tiers available at higher monthly rates.
Conclusion: SnagRx vs bmiMD and how to choose
SnagRx vs bmiMD comes down to whether you prioritize the lowest locked-in annual price for compounded semaglutide and named pharmacy and clinician details, or whether you prefer multi-tier billing, 24/7 clinician access, and a focus on compounded tirzepatide. Both use compounded medications that are not FDA-approved and both require clinician determination of medical appropriateness.
Choose SnagRx if you want bottom-of-market annual pricing for compounded semaglutide, a price lock at every dose, named US 503A partner pharmacies, and next-day shipping. Choose bmiMD if you prefer compounded tirzepatide with multiple billing options, 24/7 clinician access, and free subscription shipping.